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Gene expression data obtained in mouse heart indicate that increased expression for the nuclear receptor, peroxisomal prolif-
erator activated receptor α (PPARα), prompts the postnatal transition from predominantly carbohydrate to fatty acid oxidation
preference. However, no phenotypic or proteomic data are available to conﬁrm downstream signaling and metabolic transition
in mice. We studied the hypothesis that shifts in nuclear receptor expression trigger the newborn metabolic switch in a newborn
sheep. This species is well characterized with regards to developmental changes in substrate oxidative metabolism. Heart tissues
from fetal (130 days gestation), newborn ≤ 24 hours, and 30-day old lambs were evaluated for protein expression from multiple
enzymes controlling oxidative metabolism as well as principal nuclear receptors and coactivators. Although muscle and liver type
carnitine palmitoyl transferases I showed no signiﬁcant changes to correspond to the metabolic transition, hexokinase II protein
content showed a profound transient drop, and pyruvate dehydrogenase kinase steadily increased. PPARα showed no increases
preceding or during the transition, while peroxisomal proliferator activated receptor gamma coactivator-1 (PGC-1) increased ap-
proximately 20-fold transiently in newborn heart in conjunction with signiﬁcant increases in thyroid hormone receptor α1a n d
retinoid-activated receptor α. These data challenge the paradigm that increases in PPARα prompt the postnatal metabolic switch,
and suggest that other nuclear receptors play a major role. As thyroid hormone (TH) modulates PGC-1 expression in sheep during
development, these data further suggest that well-characterized perinatal TH surge in sheep contributes to this metabolic switch.
Copyright © 2008 Norman E. Buroker et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
The fetal heart uses glucose and lactate as the main ox-
idative substrate sources, then switches to fatty acids as
the predominant fuel shortly after birth [1]. Rapid expan-
sion of mitochondrial pool as well as total oxidative capac-
ity accompanies the perinatal metabolic transition. Initial
newborn suckling likely stimulates release of hormonal fac-
tors, which trigger modiﬁcation of substrate preference. Re-
cent data indicate that multiple nuclear receptors and their
coactivators initiate transcriptional events controlling both
newborn substrate switching and perinatal mitochondrial
biogenesis.
The nuclear receptor family includes classical endocrine
receptors activated by ligands such a thyroid hormone
or steroid hormones. Other more recently identiﬁed nu-
clear receptors (NR) respond to dietary-derived lipid in-
termediates involved in the metabolism of these activat-
ing ligands. In particular, the fatty acid-activated peroxi-
some proliferator-activated receptors (PPAR) participate as
key regulators of cardiac energy metabolism. The hormones
or ligands for the nuclear receptors attach to their respec-
tive ligand binding domains. These receptors will attach
to DNA response elements (REs) of their target genes as
monomers, homodimers, or partner as heterodimers [2, 3].
Many NRs involved in metabolic regulation heterodimer-
ize with retinoid X receptor, creating a potential mecha-
nism for regulatory integration. Ligand binding promotes
a permissive receptor conformation for coactivator inter-
action. Coactivators such as PPARγ coactivator-1 (PGC-
1) bind the receptor in the process of establishing a tran-
scriptional complex with RNA polymerase-2 to initiate2 PPAR Research
transcription of target genes [3–5]. PGC-1 enhances trans-
activation mediated by numerous nuclear receptors involved
in energy metabolism and mitochondrial biogenesis, thereby
providing a second mechanism for integration of these
processes.
Although NR-mediated control of cardiac energy
metabolism has been examined with gain or loss of function
using transgenic models, developmental regulation of these
processes has not been studied in detail. Messenger RNA
expression studies have provided the prevailing evidence for
the PPAR and PGC-1 triggering of the cardiac metabolic
switch after birth. However, multiple NRs are subject to
several post-transcriptional processes including alternate
heteronuclear RNA splicing and diﬀering translation site
initiation, as well as end-product feedback inhibition. For
the most part, regulatory patterns have not been conﬁrmed
at the protein expression level. Accordingly, we studied
developmental integration and coordination of protein
expression for three major nuclear receptor families involved
in regulation of both cardiac metabolism and mitochondrial
biogenesis: thyroid hormone receptors (TRs), PPARs, and
RXRs.ThisstudyincludedanalysesofPGC-1,asitprovidesa
coactivator function for both TRs and PPARs. Furthermore,
previous studies involving NR regulation of developmen-
tal metabolic switching have been performed in mice, a
poorly characterized species with regard to newborn cardiac
metabolism [6]. Since substantial data is available deﬁning
developmental cardiac energy metabolism in sheep, we
used this species to test the hypothesis that nuclear receptor
signaling prompts the newborn metabolic switch. The data
obtained in this well-characterized species challenge existing
paradigms regarding triggering for the postnatal metabolic
transition.
2. MATERIALS AND METHODS
2.1. Animalsamples
Domestic sheep (Ovis aries) were used for our study. Heart
samples were collectedat130 days into gestation (F), one day
after birth (N), and 30 days after birth (C) (n = 6, from each
group). Heart tissue from the left ventricle was quickly blot-
ted dry, frozen in liquid nitrogen, and stored at −80◦C. Our
investigation conforms to the G u i d ef o rt h eC a r ea n dU s eo f
Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85-23, revised 1996). The
Animal Care Committee of the University of Washington ap-
proved all animal protocols.
2.2. Proteinisolation
The frozen heart tissue was diced and homogenized at 4◦Ci n
a three-fold amount of protein lyses buﬀer (50mM Tris-Cl,
pH 8.0, 100mM NaCl, 20mM HEPES, pH 7.9, 1% Triton
X-100, 10mM NaF, 1mM Na3VO4, 100ug/ml C7H7FO2S,
5ug/ml Aprotinin, and 5ug/ml Leupeptin). The samples
were then incubated on ice for 30 minutes and centrifuged
at 10,000rpm for 10 minutes at 4◦C. The supernatant was
transferred to another microfuge tube and centrifuged one
more time. The supernatant was stored at −80◦Cf o ri m -
munoblotting analysis.
2.3. Immunoblotting
Fifty micrograms of total protein extracts from sheep heart
tissue were electrophoresed along with one lane contain-
ing thirty micrograms of human HeLa cells as a posi-
tive control and one lane of molecular weight size mark-
ers(ChemichromeWesternControl,Sigma-AldrichCo.,Mo,
USA) in a 4.5% stacking and 7.5, 10, or 12% running SDS-
polyacrylamidegeldependingonthemolecularweightofthe
protein of interest. The gels were then electroblotted onto
polyvinylidene ﬂuoride (PVDF) plus membranes. The west-
ern blots were blocked for one hour at room temperature
with either a 1% or 5% nonfat milk (depending on the an-
tibodies requirements) in Tris-buﬀered saline plus Tween-
20 (TBST)[10mM Tris-HCl, pH 7.5, 150mM NaCl, and
0.05% Tween-20], followed by overnight incubation at 4◦C
witheachprimaryantibodydilutedintheappropriateblock-
ing solution as recommended by the supplier. The primary
antibodies used in the study are β-actin (SC-1616), HK2
(SC-6521), MTCO3 (SC-23986), PGC-1 (SC-5814), PPARα
(SC-9000), and RXRα (SC-553) obtained from (Santa Cruz
Biotechnology, Inc., Calif, USA). The primary antibody TRα
(PA1-211A) was obtained from (Aﬃnity BioReagents, Inc.,
CO, USA). The primary antibodies L&M-CPTI and PDK2
were obtained as personal gifts from Gebre Woldegiorgis
andRobertHarris,respectively.Aftertwoﬁve-minutewashes
with TBST and one ﬁve-minute wash with Tris-buﬀered
saline (TBS), membranes were incubated at room temper-
ature for one hour with the appropriated secondary an-
tibody conjugated to horseradish peroxidase (HRP). The
membranes were washed twice for ten minutes with TBST
and visualized with enhanced chemiluminescence after ex-
posure to Kodak biomax light ML-2 ﬁlm. The membranes
werestrippedbywashingthemtwotimesfor30minuteswith
200mM Glycine, 0.1% SDS, and 1% Tween-20 (pH adjusted
to 2.2), followed by three ten-minute washes with TBS. The
membranes were again blocked for one hour as above, fol-
lowed by overnight incubation at 4◦Cw i t hβ-Actin antibody
diluted 1 : 200 in blocking solution. The next day, the mem-
branes were washed (as above), the appropriate secondary-
HRPantibodywasapplied,andtheremainingprocedures(as
described above) were followed. The β-actin was used to ver-
ify protein lane loadings.
2.4. Statisticalanalysis
The ﬁlm expression was determined using the ImageJ 1.32j
program produced by Wayne Rasband for (the National In-
stitute of Health, Md, USA). The protein expression was
standardized against β-Actin and the means and standard er-
rors for the three stages of heart development are displayed
in a histogram (Figure 1). Statistical signiﬁcance was deter-
mined with Student’s t-test (two tailed) comparison between
all stages of development.Norman E. Buroker et al. 3
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Figure 1: Immunoblots and expression patterns for enzymes controlling substrate oxidation. Data is shown for left ventricle from three
development periods (F, N, C) as deﬁned in text. Abbreviations are carnitine palmitoyltransferase I (muscle isoform M-CPTI), carnitine
palmitoyltransferase I (liver isoform L-CPTI), hexokinase 2 (HK2), and pyruvate dehydrogenase kinase 2 (PDK2). M-CPTI protein expres-
sion decreases occurred between N and C (∗P<. 01). L-CPTI protein expression diﬀerences decreased immediately after birth F (∗P<. 01)
andcontinuedtodropinC(+P<0.001,versusN).HK2proteinexpressionexhibitedamarkedbuttransientdecreaseafterbirthN(∗P<. 05,
versus F & C). PDK2 protein expression increased with signiﬁcance noted in C compared to F and N (∗P<. 05, F & N).
3. RESULTS
3.1. Carnitinepalmitoyltransferases
The enzyme carnitine palmitoyltransferase I (CPT I; pal-
mitoyl-CoA:L-carnitine O-palmitoyltransferase; EC 2.31.21)
is a rate-limiting step in mitochondria transport during FA
oxidation. It catalyzes the initial reaction of acyl-CoA and
carnitine to acylcarnitine during the mitochondria import
of long-chain FAs into the inner mitochondria membrane.
PPAR regulates CPTI and turns the gene on during the FA
oxidationcascadeofeventsshortlyafterbirth[7,8].Inmam-
malian heart, there are two CPTI isoenzymes: a liver, L-CPTI
isoenzyme, also known as CPTIα: and a muscle, M-CPTI
isoenzyme, also known as CPTIβ [9, 10] In human tissue,
the L-CPTI protein is composed of 773 amino acids that
corresponds to a molecular weight of 88.3kDa [P50416]. In
sheepheart,theL-CPTIisoenzymecorrespondstoamolecu-
lar weight of 82kDa (Figure 3), which is smaller than that re-
portedinhumantissue,butinagreementwithwhathasbeen
reported in fetal and newborn lambs [9]. In human tissue,
the M-CPT I protein is composed of 772 amino acids which
corresponds to a molecular weight of 87.8kDa [Q92523].
The adult sheep protein sequence is highly conserved with
relationtoothermammalswithan89%similaritytohumans
and 88% similarity to mouse and rat [11]. In sheep heart, the
M-CPTI antibody recognizes an 88-kDa isoenzyme consis-
tently expressed in the three study groups (Figure 1). The 88-
kDa protein corresponds to the 771 amino acids reported for
M-CPTI in sheep [C81315], but is in disagreement with the
80-kDa protein that has been previously reported in sheep
[9]. In this study, the M-CPTI (Figure 3(a)) and L-CPTI
(Figure 3(b)) protein expression was signiﬁcantly greater in
the day old samples then in the 30-day old samples, while
the L-CPTI protein expression was signiﬁcantly greater in
the fetal then in either the day old or 30-day old samples
(Figure 1).
3.2. Hexokinase
Hexokinase (HK, E.C.2.7.1.1) in mammalian tissues exist
as four isoenzymes (HK1-4) with distinct kinetic properties
and tissue distribution [12]. The hexokinases are rate lim-
iting glycolytic enzymes that catalyze the phosphorylation of
glucosetoglucose-6-phosphate[13].HKtype2andHKtype
4 are found in heart tissue [14] . In sheep heart, the HK2
antibody detects a 102-kDa protein among the three study
groups (Figure 1). The 102-kDa protein corresponds to the
molecular weight of the human HK2 isoenzyme with 917
amino acids [P52789]. A 102-kDa protein was also detected
by this antibody in a HeLa human cell line obtained from4 PPAR Research
(Santa Cruz Biotechnology, Inc., Calif, USA) (data not in-
cluded). In this study, we monitored the appearance of HK2
during the three stages of sheep development and found a
signiﬁcant decrease in HK2 protein expression for the day
old samples compared to either the fetal or 30-day old sam-
ples. This ﬁnding indicates that a reduction in glycolysis at
birth due to the onset of FAO.
3.3. Pyruvatedehydrogenasekinase
The isoenzyme pyruvate dehydrogenase kinase 2 (PDK2;
pyruvate dehydrogenase [lipoamide] kinase isoenzyme 4; EC
2.7.1.99) is one of four PDK isoenzymes found in mam-
malian tissues. PDK2 is expressed at high levels in heart tis-
sue [15–17] and is regulated by PPARα [18]. The enzyme is
responsible for phosphorylation of pyruvate dehydrogenase
(PDH), a mitochondrial multienzyme complex, rendering it
inactive. The PDH catalyzes the oxidative decarboxylation of
pyruvate,linkingglycolysistothetricarboxylicacidcycleand
FA synthesis [18]. Increased levels of PDK in early postna-
tal life for PDH inactivation are thought to be the result of
changes in lipid supply and a switch from glucose to FAs as
an energy supply [19].Inaddition to hexokinase, PDKis also
a rate-limiting step in the glycolytic pathway [20, 21]. In hu-
man tissue, the PDK2 isoenzyme is composed of 407 amino
acids which corresponds to a molecular weight of 46kDa for
the isoenzyme [Q15119]. PDK2 has its strongest expression
in the day old (N) sheep samples. In sheep heart, the PDK2
antibody detects a 46-kDa protein among the three study
groups(Figure 1).A47-kDaproteinwasalsodetectedbythis
antibody in a HeLa human cell line obtained from (Santa
Cruz Biotechnology, Inc., Calif, USA) (data not included). In
this study, PDK2 protein expression levels were signiﬁcantly
greater in the 30-day old (C) samples when compared to ei-
ther fetal (F) or the one-day old (N) samples; (Figure 1) in-
dicating the switch from glucose to FAO.
3.4. Mitochondrialproteinsinvolvedwith
cardiacenergymetabolism
With the beginning of aerobic development at birth there
is a rapid deployment of new mitochondria in cardiac cells
to handle the FA energy metabolism and ATP output [22].
The mitochondrial genome must be running near full capac-
ity with genome replication for new mitochondria as well as
the transcription of mitochondria genes [23]i no r d e rt oa c -
commodate this expansion. We used protein expression for
the cytochrome c oxidase 3 as a reporter for mitochondrial
biogenesis. Cytochrome c oxidase 3 (MTCO3; Cytochrome c
oxidase polypeptide 3; E.C. 1.9.3.1) is one of three subunits
transcribed in the mitochondria from a total of 13 subunits
that make up cytochrome c oxidase. The remaining ten sub-
unitsaretranscribedfromnucleargenes[23].Insheepheart,
the MTCO3 antibody detects a 30-kDa molecular weight
protein, which represents the cytochrome c oxidase 3 in the
three study groups. MTCO3 protein expression is greater in
N then either the F or C (Figure 2). We did not see compara-
ble changes for the nuclear cytochrome c oxidase, subunit 4,
(NCO4) gene (data not included). This diﬀerence between
the expression of mitochondria and nuclear cytochrome c
oxidase subunits during mitochondria biogenesis has previ-
ously been reported [24].
3.5. Peroxisomeproliferator-activatedreceptor-γ
co-activator1(PGC-1)
Insheep,thePGC-1antibodyrecognizesthePGC-1αprotein
or the 91-kDa isoform, while the PRC and PGC-1β isoforms
were not detected among the three study groups (Figure 2).
PGC-1α displays a signiﬁcant increase in protein expression
in the day old samples (N) compared with either the fetal (F)
or 30-day old samples (C), while the 30-day old samples (C)
were found to have a signiﬁcantly greater protein expression
level than the fetal samples (F). In a previous sheep study,
we noted that PGC-1 protein expression was near threefold
g r e a t e ri nCt h a ni nF .
3.6. Peroxisomeproliferator-activated
receptors(PPARα)
The PPARα antibody detects the 52-kDa nuclear receptor at
each stage of development (Figure 3). In human tissues, the
PPARαproteiniscomposedof478aminoacidsthatreﬂectsa
molecular weight of 52kDa [Q07869], which coincides with
the molecular weight observed in sheep. The 52-kDa protein
was also detected by this antibody in a HeLa human cell line
obtained from (Santa Cruz Biotechnology, Inc., Calif, USA)
(data not included). The protein expression of the PPARα
nuclear receptor was found to be signiﬁcantly lower in the
30-day old samples (C) when compared to the Fetal (F) and
the day old samples (N) (Figure 3).
3.7. RetinoidXreceptors(RXRα)
In sheep heart, the RXRα antibody detects the 51-kDa nu-
clear receptor at each stage of development (Figure 3)c o r r e -
sponding to the full length RXRα is 462 amino acids, which
represents a molecular weight of 51kDa [P19793]. We noted
a small but signiﬁcant surge in RXRα expression in the one-
day old sheep heart (Figure 2(b)).
3.8. Thyroidhormonereceptor(TRα1)
In sheep heart, the TRα1 antibody detects the 47-kDa nu-
clear receptor among the three study groups (Figure 3). In
humans and rodents, the full length of TRα is 410 amino
acids, which corresponds to a molecular weight of 47kDa.
In this study, the THRα1 nuclear receptor has a signiﬁcantly
greater level of protein expression in the day old samples (N)
compared with either the fetal (F) or the 30-day old samples
(C) (Figure 3).
3.9. Othernuclearreceptorisoformsand
metabolicproteinsofinterest
Antibodiesagainstotherproteinexpressionwereused.These
include PPARβ,P P A R γ,R X R β,T R α2, TRβ, MYLCD, and
PDK4. Unfortunately, a cross reactivity exists between theNorman E. Buroker et al. 5
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Figure 2: Cytochrome c oxidase 3 expression serves a reporter for the mitochondrial genome (MTCO3; Cytochrome c oxidase polypeptide
3; E.C. 1.9.3.1). MTCO3 increased transiently in the newborn (∗∗P<. 01, versus F & C). Coordinate changes in protein content occurred
for PGC-1α, implicated as a regulator of mitochondrial biogenesis.
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Figure 3: Content for nuclear receptors peroxisome proliferator-activated receptor (PPARα), (b) retinoid X receptor alpha (RXRα), and
thyroid hormone receptor (TRα1) among three stages (F, N, C). Modest transient but signiﬁcant elevations for RXRα and TRα1 occurred in
Nc o m p a r e dt ob o t hFa n dC( ∗P<. 01). PPARα expression did not change immediately after birth, but later decreased compared to F and
N( ∗P<. 01).
secondary antibodies (i.e., those with goat, mouse, and rab-
bit hosts for the primary antibodies) and the one-day and
30-dayoldstagesofdevelopmentinoursheepsamples.Con-
sequently, we could not get reliable data for these proteins of
interest.
4. DISCUSSION
Several investigations have established the time course for
maturation of cardiac energy metabolism in the sheep model
in vivo. For instance, Bartelds et al. [1] showed that glucose
and lactate were the prime energy substrates during ovine
fetal life, and the switch to fatty acids as prime oxidative sub-
strate occurred within 2–16 days after birth [1, 25]. Our lab-
oratory has shown that regulation of myocardial oxidative
phosphorylation matures within the same age period in par-
allel with accumulation of the adenine nucleotide translo-
cator protein [26]. Considered in summation, these studies
indicate that postnatal transitions in oxidative phosphory-
lation and substrate oxidation occur coordinately and their
regulation is integrated through a unifying signaling mech-
anism. The nuclear receptors, operating in conjunction with
theircoactivators,oﬀerapotentialmechanismforrapidlyin-
tegrating these processes shortly after birth.
Fattyacidandcarbohydratemetabolismgenerallyexhibit
reciprocal type regulatory patterns, where one decreases as
the other increases [27]. Prior work in the newborn sheep
heart has focused on carnitine palmitoyl transferase I as the
pivotal enzyme determining the preferential shift for fatty
acid oxidation over carbohydrate utilization. Bartelds et al.
[1] detected postnatal increases in CPTI activity and pro-
tein content, which were much lower than the increase in
the rate of LC-FA oxidation in vivo in the same animals.
Furthermore, they found relatively high rates of CPTI ac-
tivity in fetal lambs [9]. These data led to their contention
that substrate supply was the major determinant for the in-
crease preference for LC-FA oxidation around birth. Simi-
larly,ourdatashowsteadydeclineinL-CPTIimmediatelyaf-
ter birth with maintained M-CPTI protein levels, and imply
that CPTI activity or content does not regulate the postna-
tal metabolic transition in sheep. Studies in rabbit heart have
also shown that the postnatal increases in fatty acid ﬂux do
not relate to CPTI-content, isoform pattern or activity. The
increase in fatty acid oxidation in the rabbit heart relates di-
rectly to a reduction in levels of malonyl-CoA decarboxylase
(MYLCD), an inhibitor of CPTI. PDH activity also increases
in postnatal rabbit myocardium despite decreases in glucose
oxidation.6 PPAR Research
In our sheep studies, we show for the ﬁrst time changes
in ovine expression for myocardial hexokinase 2 during de-
velopment. This enzyme catalyzes glucose phosphorylation,
a rate limiting step in glucose oxidation and positioned
upstream from pyruvate dehydrogenase. Although, glucose
transport across the sarcolemma is controlled in part by
glucose transporters (GLUT1 and GLUT4), which are ex-
pressed abundantly in the fetal sheep heart [28], hexokinase-
2 has emerged recently as the rate limiting glucose oxida-
tion step during periods of stress [21, 29]. We also found
modest but late postnatal increases for PDK2, which are
consistent with inhibition of pyruvate dehydrogenase ﬂux.
Thus, our data imply that inhibition of the glucose oxida-
tion pathway contributes to the postnatal metabolic switch
with reciprocal and indirect activation of fatty acid oxidation
accompanying.
The paradigm of PPARα activation serving as the pri-
mary signaling mechanism for the postnatal myocardial
metabolic switch has been propagated solely by studies
demonstrating increases in PPARα and PGC-1 mRNA lev-
e l si nm i c eo rr a t sd u r i n gd e v e l o p m e n t[ 4, 30]. Supportive
developmental expression studies for the corresponding pro-
teins or their activity are lacking in the literature for these
species. Furthermore, no published data, that we are aware
of, is available regarding the occurrence and timing of the
postnatal metabolic switching in either of these species. Ex-
tensive literature search reveals no studies regarding myocar-
dial substrate oxidation patterns near or after birth in these
species. Rather, mRNA data from rodents has been extrapo-
lated to describe signaling for postnatal phenomenon char-
acterized in larger species such as sheep, rabbit [31], and pigs
[32–34]. This interpretative approach is of dubious value, as
we have previously shown that mRNA levels for these nu-
clear receptors and coactivators demonstrate no coordina-
tion with protein content in the postnatal period [35]. Re-
sults from previous work in sheep imply that steady-state
mRNA levels from PPARα and PGC-1 are subject to auto
feedback from respective proteins. The dramatic changes in
content for the proteins controlling cardiac substrate and ox-
idative metabolism, such as hexokinase-2, and cytochrome
c oxidase, are not preceded by elevation in PPARα protein
abundance. Hence, our study indicates that PPARα protein
content plays no role in initiating the immediate postnatal
upregulation of these metabolic proteins.
Though the data challenge the concept that postna-
tal increases in PPARα steady-state mRNA coordinates the
metabolic shift, they do not eliminate a role for enhanced
PPARα-mediated transactivation of target genes. In the cur-
rent model, PPARα activity might be increased through si-
multaneous coactivation by PGC-1α, heterodimer forma-
tion through increased RXR availability, and enhanced lig-
and availability generated by newborn suckling and fatty
acid intake. However, we have little downstream evidence for
increased PPARα transcriptional activity. On the contrary,
knownPPARαtargets,suchasLCPTI,MCPTI,andPDK2are
not overtly elevated in terms of protein content during the
immediate period after birth. Finally, hexokinase-2, rapidly
upregulatedbythePPARαantagonistWY14643inmice[36],
shows a marked depression in this model.
PGC-1 remains an attractive candidate as a primary
regulator for the postnatal myocardial transition, as this
factor also appears to coordinate cross-talk between mito-
chondrial and nuclear genomes during development [24].
We have previously shown that gene and protein expres-
sion for nuclear-encoded adenine nucleotide translocator
increases in sheep heart by 28–30 days after birth [26].
In the current study, we demonstrate that the mitochon-
drial encoded respiratory chain component, MTCO3 in-
creases near four-fold in conjunction with the robust change
in PGC-1. As PGC-1 and MTCO3 change coordinately,
the data imply that PGC-1 coordinates substrate switch-
ing along with mitochondrial membrane expansion by af-
fecting the mitochondrial genome. PGC-1 also closely links
to total functional cytochrome c oxidase (Cyt aa3)a n dc y -
tochrome c (Cyt c) content and respiratory capacity dur-
ing postnatal ovine heart development [35]. However, we
found no concomitant change in the nuclear-encoded cy-
tochrome c oxidase, subunit 4. This ﬁnding suggests that
content for nuclear-encoded components are adequate in
the fetus, but that rapid postnatal mitochondrial biogene-
sis depends on PGC-1 promotion of mitochondrial encoded
components.
This study was designed to sample three points dur-
ing sheep development, which would determine the tem-
poral relationship between protein expression and the well-
documented late fetal and immediate postnatal surge in cir-
culating thyroid hormone [37]. Since, multiple changes in
hormone concentrations and environment occur during this
time period, we cannot prove without a doubt that this
change in thyroid hormone homeostasis exclusively causes
increases in PGC-1 and nuclear receptors. However, thy-
roidectomy immediately after birth abrogates the postna-
tal thyroid hormone surge, reduces PGC-1α levels [35], and
attenuates expansion of mitochondrial membrane protein
content and respiratory capacity [38]. This observation sup-
ports the contention that thyroid hormone plays an impor-
tant role in signaling the postnatal metabolic transition in
heart. Our data from prior work and the current study sug-
gest that T3 simultaneously elevates PGC-1α, and binds as
a ligand to the TRs, which also exhibit increased expres-
sion, during this critical developmental period. These co-
ordinated events would lead to increased transactivation of
metabolic target genes by TRs and PPARs when binding as
heterodimers with RXRs.
In summary, our data challenge speciﬁc concepts regard-
ing the importance of PPARα protein expression in control
of the postnatal metabolic switch. First, we showed that al-
terations in hexokinase-2, a rate limiting step in glucose ox-
idation, accompany the transition. These data suggest that
inhibition of glucose oxidation reciprocally stimulates fatty
acid ﬂux, as opposed to a direct increase in enzyme expres-
sion and /or activity of CPTI. Secondly, we demonstrate that
no increase in PPARα protein occurs prior to the postnatal
metabolic switch in sheep. Thus, transcriptional mediation
of this protein does not trigger the change in substrate pref-
erence. However, a robust postnatal increase in PGC-1 and
the PPARα binding partner, RXRα, does provide conditions
for enhanced PPARα activity.Norman E. Buroker et al. 7
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